Codexis, Inc. develops biocatalysts for the pharmaceutical and fine chemicals markets in the United States, Europe, and Asia. Codexis’ proven technology enables scale-up and implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable process development — from research to manufacturing. The company sells its products through its direct sales and business development force. For more information, visit the company’s website at www.codexis.com.